Diego Wyszynski MD MHS, PhD
VP, Pregnancy and Lactation Studies, Thermo Fisher Scientific
Join to View Full Profile
1801 Century Park EastLos Angeles, CA 90067
Dr. Wyszynski is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Diego Wyszynski, based in London, England, is a renowned expert in epidemiology and maternal health research, with a focus on pregnancy and medication safety. He earned his medical degree from the University of Buenos Aires and both a Master of Health Science and a PhD in Epidemiology from Johns Hopkins School of Hygiene and Public Health. Dr. Wyszynski founded Pregistry, a global leader in pregnancy safety studies, which was acquired by CorEvitas in 2022. Following CorEvitas’ acquisition by Thermo Fisher Scientific in 2023, he now serves as Vice-President of Pregnancy and Lactation Studies. With over 90 peer-reviewed publications, including significant work on SARS-CoV-2 in pregnancy and medication use, he has also authored three books on birth defects published by Oxford University Press. In 2017, he was honored as a TEDMED Research Scholar.
Clinical Expertise
- Pregnancy, Epidemiologic typing, Epidemiology, Consultative service to pharmaceutical companies, Pregnancy registries, Drug Safety and Pharmacovigilance
Education & Training
University of Buenos AiresClass of 1991
Johns Hopkins School of Hygiene and Public HealthMHS, Epidemiology- Johns Hopkins School of Hygiene and Public HealthPhD, Epidemiology
Awards, Honors, & Recognition
- TEDMED Research Scholar TEDMED, 2017
Clinical Trials
- COVID-19 Vaccines International Pregnancy Exposure Registry Start of enrollment: 2021 Jun 01
- COVID-19 International Drug Pregnancy Registry Start of enrollment: 2021 Dec 01
- Pregistry International Pregnancy Exposure Registry (PIPER) Start of enrollment: 2022 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- 4 citationsAssociation between SARS-CoV-2 infection during pregnancy and postpartum depressive and anxiety symptoms: finding from the International Registry of Coronavirus Exposu...Sonia Kim, Sonia Hernández-Díaz, Yanmin Zhu, Diego Wyszynski, Krista F Huybrechts
Archives of Women's Mental Health. 2022-12-01 - 23 citationsPregnancy and Birth Outcomes among Women with Idiopathic Thrombocytopenic PurpuraDiego F. Wyszynski, Wendy J. Carman, Alan B. Cantor, John M. Graham, Liza Kunz
Journal of Pregnancy. 2016-03-22 - 11 citationsFrequency and type of medications and vaccines used during pregnancyDiego F Wyszynski, Kristine E Shields
Obstetric Medicine. 2016-03-01
Press Mentions
Dr. Cheryl Renz Joins Pregistry as Chief Medical OfficerMay 18th, 2022
Announcing the TEDMED 2017 Research ScholarsMarch 1st, 2017
Study Finds Anticonvulsant Drug Poses Greater Birth-Defect Risk Than SuspectedMarch 22nd, 2005- Join now to see all
Professional Memberships
- International Society of Pharmacovigilance (ISoP)Member
Other Languages
- Spanish
External Links
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
